This week in Other Barks & Bites: the Ninth Circuit rules that service on the USPTO Director under Section 1051(e) for reaching foreign-domiciled defendants applies in U.S. district court proceedings; the Federal Circuit restores a patent claim owned by VLSI Technology on the same day that a Western Texas jury enters a $948 million verdict for VLSI against Intel; the Eighth Circuit affirms a summary judgment ruling that Pocket Plus’ asserted trade dress is functional; the European Patent Office will begin transitional measures on unitary patents for patent applicants on January 1 of next year; major tech firms including Amazon and Twitter have been shedding large amounts of employees; AMD and Analog Devices announce a settlement agreement ending ongoing patent litigation between the firms; and the Supreme Court of Canada affirms a damages award for patent infringement including “springboard” profits earned by the infringer after the asserted patent rights expired.
Patent
- Enablement
- Fee Shifting
- Litigation
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments
Recent Posts
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments